Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Status:
Completed

Trial end date:
2006-08-01

Target enrollment:

Participant gender:

This purpose of this study is to evaluate the safety and efficacy of Licarbazepine for the treatment of manic episodes of bipolar disorder.

Phase 3

Novartis Pharmaceuticals